419 related articles for article (PubMed ID: 24914740)
1. A simple method to identify patients on long-term warfarin who may derive the most benefit from new oral anticoagulants.
Carrier M; Kimpton M; Wells PS; Langlois N; Kherani S; Le Gal G
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):812-5. PubMed ID: 24914740
[TBL] [Abstract][Full Text] [Related]
2. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
[TBL] [Abstract][Full Text] [Related]
3. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
Caldeira D; Cruz I; Morgado G; Stuart B; Gomes AC; Martins C; João I; Pereira H
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):972-6. PubMed ID: 26083988
[TBL] [Abstract][Full Text] [Related]
4. Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.
Vijenthira A; Le Gal G; Castellucci LA; Carrier M
Thromb Res; 2014 Sep; 134(3):584-6. PubMed ID: 25037497
[TBL] [Abstract][Full Text] [Related]
5. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-life data from a survey in Eastern Switzerland.
Maeder MT; König T; Bogdanovic S; Schneider I; Eugster W; Ammann P; König M; Beer J; Rickli H
Swiss Med Wkly; 2017; 147():w14503. PubMed ID: 29039622
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
[TBL] [Abstract][Full Text] [Related]
7. Prediction Score for Anticoagulation Control Quality Among Older Adults.
Lin KJ; Singer DE; Glynn RJ; Blackley S; Zhou L; Liu J; Dube G; Oertel LB; Schneeweiss S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982676
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.
Caldeira D; Cruz I; Morgado G; Stuart B; Gomes C; Martins C; João I; Pereira H
BMC Res Notes; 2014 Dec; 7():891. PubMed ID: 25491419
[TBL] [Abstract][Full Text] [Related]
9. Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE.
Barco S; Granziera S; Coppens M; Douxfils J; Nijkeuter M; Riva N; Vanassche T; Zhang G; Lin M; Kamphuisen PW; Cohen AT; Beyer-Westendorf J
Thromb Haemost; 2019 Apr; 119(4):675-684. PubMed ID: 30731492
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
Demelo-Rodríguez P; Postigo-Esteban A; García-Fernández-Bravo I; Agud M; Calpena S; Camacho M; Del Toro-Cervera J
Thromb Res; 2016 Nov; 147():58-60. PubMed ID: 27676254
[TBL] [Abstract][Full Text] [Related]
11. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
Le Heuzey JY; Ammentorp B; Darius H; De Caterina R; Schilling RJ; Schmitt J; Zamorano JL; Kirchhof P
Thromb Haemost; 2014 May; 111(5):833-41. PubMed ID: 24651882
[TBL] [Abstract][Full Text] [Related]
12. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
[TBL] [Abstract][Full Text] [Related]
13. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
15. A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment.
Riva N; Vella K; Meli S; Hickey K; Zammit D; Calamatta C; Makris M; Kitchen S; Ageno W; Gatt A
Int J Lab Hematol; 2017 Oct; 39(5):482-488. PubMed ID: 28500649
[TBL] [Abstract][Full Text] [Related]
16. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study.
Palareti G; Antonucci E; Lip GY; Testa S; Guazzaloca G; Falanga A; Pengo V; Poli D;
Thromb Haemost; 2016 Jun; 115(6):1101-8. PubMed ID: 26819229
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa.
Mwita JC; Francis JM; Pillay C; Ogah OS; Goshu DY; Agyekum F; Musonda JM; James MC; Tefera E; Kabo T; Ditlhabolo KI; Ndlovu K; Ayodele AY; Mkomanga WP; Chillo P; Damasceno A; Folson AA; Oyekunle A; Tebuka E; Kalokola F; Forrest K; Dunn H; Karaye K; Jean-Pierre FL; Oljira CF; Tadesse TA; Taiwo TS; Nwafor CE; Omole O; Anakwue R; Cohen K
J Thromb Thrombolysis; 2024 Apr; 57(4):613-621. PubMed ID: 38478250
[TBL] [Abstract][Full Text] [Related]
19. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
